Tag: Cancer research
David Epstein launches new cancer startup after Novartis and Seagen career
David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop a drug that targets two proteins, PD-1 and VEGF, in...
Biden’s ‘Moonshot’ Initiative: Reducing Cancer Deaths in Final Months of Office
President Joe Biden is focusing on his administration's "moonshot" initiative to reduce cancer deaths as he nears the end of his term. He plans to cut U.S. cancer fatalities by 50% over the next...
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly), is an immunotherapy-based drug made by British pharmaceutical company GSK....
The Cost of Cancer Screening: A $43 Billion Annual Expense
The United States spends a significant amount of money on cancer screening each year, with estimates showing that $43 billion was spent in 2021 alone. This cost is attributed to screening for five specific...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...